• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA 甲基化和组蛋白修饰作为前列腺癌的表观遗传调控(综述)。

DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).

机构信息

Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland.

出版信息

Oncol Rep. 2017 Nov;38(5):2587-2596. doi: 10.3892/or.2017.5972. Epub 2017 Sep 20.

DOI:10.3892/or.2017.5972
PMID:29048620
Abstract

Prostate cancer is the second most commonly diagnosed cancer in men in Poland after lung cancer and the third leading cause of cancer-related mortality after lung and colon cancer. The etiology of most cases of prostate cancer are not fully known, and therefore it is essential to search for the molecular basis of prostate cancer and markers for the early diagnosis of this type of cancer. Epigenetics deals with changes in gene expression that are not determined by changes in the DNA sequence. Epigenetic changes refer to changes in the structure of DNA, which are the result of DNA modification after replication and/or post-translational modification of proteins associated with DNA. In contrast to mutations, epigenetic changes are reversible and occur very rapidly. The major epigenetic mechanisms include DNA methylation, modification of histone proteins, chemical modification and chromatin remodeling changes in gene expression caused by microRNAs (miRNAs). Epigenetic changes play an important role in malignant transformation and can be specific to types of cancers including prostate cancer.

摘要

在波兰,前列腺癌是男性中仅次于肺癌的第二大常见癌症,也是肺癌和结肠癌之后导致癌症相关死亡的第三大主要原因。大多数前列腺癌病例的病因并不完全清楚,因此寻找前列腺癌的分子基础和用于早期诊断这种癌症的标志物至关重要。表观遗传学涉及基因表达的变化,而这些变化不是由 DNA 序列的变化决定的。表观遗传变化是指 DNA 结构的变化,这是复制后 DNA 修饰和/或与 DNA 相关的蛋白质的翻译后修饰的结果。与突变不同,表观遗传变化是可逆的,并且发生得非常迅速。主要的表观遗传机制包括 DNA 甲基化、组蛋白蛋白修饰、化学修饰以及 miRNA(微小 RNA)引起的染色质重塑变化导致的基因表达变化。表观遗传变化在恶性转化中起着重要作用,并且可以针对包括前列腺癌在内的特定类型的癌症具有特异性。

相似文献

1
DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).DNA 甲基化和组蛋白修饰作为前列腺癌的表观遗传调控(综述)。
Oncol Rep. 2017 Nov;38(5):2587-2596. doi: 10.3892/or.2017.5972. Epub 2017 Sep 20.
2
Epigenetic modifications in prostate cancer.前列腺癌中的表观遗传修饰
Epigenomics. 2014;6(4):415-26. doi: 10.2217/epi.14.34.
3
Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.非编码 RNA 在食管癌表观遗传修饰中的作用。
Biomed Pharmacother. 2019 Sep;117:109192. doi: 10.1016/j.biopha.2019.109192. Epub 2019 Jul 11.
4
Epigenetic biomarkers in prostate cancer: Current and future uses.前列腺癌中的表观遗传生物标志物:当前和未来的应用。
Cancer Lett. 2014 Jan 28;342(2):248-56. doi: 10.1016/j.canlet.2012.02.011. Epub 2012 Mar 3.
5
Epigenetics in prostate cancer: biologic and clinical relevance.前列腺癌中的表观遗传学:生物学和临床相关性。
Eur Urol. 2011 Oct;60(4):753-66. doi: 10.1016/j.eururo.2011.06.035. Epub 2011 Jun 22.
6
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1.关于前列腺癌中程序性死亡受体配体1(PD-L1)表达我们需要了解什么?一项系统文献综述。第5部分:PD-L1的表观遗传调控
Int J Mol Sci. 2021 Nov 15;22(22):12314. doi: 10.3390/ijms222212314.
7
[Epigenetics of prostate cancer].[前列腺癌的表观遗传学]
Zhonghua Nan Ke Xue. 2010 Jul;16(7):635-41.
8
Epigenetic targets in the diagnosis and treatment of prostate cancer.前列腺癌诊断与治疗中的表观遗传学靶点
Int Braz J Urol. 2007 Jan-Feb;33(1):11-8. doi: 10.1590/s1677-55382007000100003.
9
DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.癌症患者的DNA甲基化和组蛋白修饰:潜在的预后和治疗靶点。
Methods Mol Biol. 2007;361:25-62. doi: 10.1385/1-59745-208-4:25.
10
Epigenetic changes in prostate cancer: implication for diagnosis and treatment.前列腺癌中的表观遗传变化:对诊断和治疗的意义。
J Natl Cancer Inst. 2005 Jan 19;97(2):103-15. doi: 10.1093/jnci/dji010.

引用本文的文献

1
Epigenetic Modifications in Osteosarcoma: Mechanisms and Therapeutic Strategies.骨肉瘤中的表观遗传修饰:机制与治疗策略
Life (Basel). 2025 Jul 28;15(8):1202. doi: 10.3390/life15081202.
2
The mechanism of histone modifications in regulating enzalutamide sensitivity in advanced prostate cancer.组蛋白修饰在调节晚期前列腺癌恩杂鲁胺敏感性中的作用机制。
Int J Biol Sci. 2025 Apr 13;21(6):2880-2890. doi: 10.7150/ijbs.109638. eCollection 2025.
3
Exploring the Relationships between Lifestyle Patterns and Epigenetic Biological Age Measures in Men.
探索男性生活方式模式与表观遗传生物学年龄指标之间的关系。
Biomedicines. 2024 Sep 2;12(9):1985. doi: 10.3390/biomedicines12091985.
4
Effects of valproic acid on wound healing of the abdominal wall musculoaponeurotic layer: an experimental study in rats.丙戊酸对大鼠腹壁肌筋膜层愈合的影响:一项实验研究。
Rev Col Bras Cir. 2024 Jun 14;51:e20243676. doi: 10.1590/0100-6991e-20243676-en. eCollection 2024.
5
Epigenetic modifications in solid tumor metastasis in people of African ancestry.非洲裔人群实体瘤转移中的表观遗传修饰
Front Oncol. 2024 Feb 21;14:1325614. doi: 10.3389/fonc.2024.1325614. eCollection 2024.
6
Dietary Plant Metabolites Induced Epigenetic Modification as a Novel Strategy for the Management of Prostate Cancer.饮食植物代谢物诱导的表观遗传修饰作为一种治疗前列腺癌的新策略。
Mini Rev Med Chem. 2024;24(15):1409-1426. doi: 10.2174/0113895575283895240207065454.
7
Epigenetic (De)regulation in Prostate Cancer.前列腺癌中的表观遗传(去)调控。
Cancer Treat Res. 2023;190:321-360. doi: 10.1007/978-3-031-45654-1_10.
8
Decoding the Influence of Obesity on Prostate Cancer and Its Transgenerational Impact.解析肥胖对前列腺癌的影响及其跨代效应。
Nutrients. 2023 Nov 21;15(23):4858. doi: 10.3390/nu15234858.
9
PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway.PCMT1 通过调控 PI3K/AKT/GSK-3β 通路调节前列腺癌细胞的迁移、侵袭和凋亡。
Aging (Albany NY). 2023 Oct 27;15(20):11654-11671. doi: 10.18632/aging.205152.
10
Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line.阿霉素与肼苯哒嗪及双硫仑对MCF - 7乳腺癌细胞系的协同联合作用
PLoS One. 2023 Sep 28;18(9):e0291981. doi: 10.1371/journal.pone.0291981. eCollection 2023.